Multiple Myeloma
Showing NaN - NaN of 141
Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)
Completed
- Multiple Myeloma
- Allogeneic HSCT
- +5 more
-
Birmingham, Alabama
- +14 more
Jan 25, 2022
Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)
Completed
- Multiple Myeloma
- Lenalidomide
- lenalidomide, bortezomib and dexamethasone
-
Tucson, Arizona
- +53 more
Dec 8, 2021
Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Selinexor
- +2 more
-
Plantation, Florida
- +156 more
Nov 23, 2021
Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)
Terminated
- Multiple Myeloma
- Waldenstrom Macroglobulinemia
-
Scottsdale, Arizona
- +18 more
Nov 15, 2021
Multiple Myeloma Trial in Atlanta (Bortezomib, Lenalidomide, Dexamethasone)
Completed
- Multiple Myeloma
- Bortezomib
- +3 more
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Nov 1, 2021
Multiple Myeloma Trial in United States (procedure, drug, behavioral)
Completed
- Multiple Myeloma
- One Autologous Transplant
- +5 more
-
Birmingham, Alabama
- +35 more
Oct 19, 2021
Subjects Treated With ACTR T Cell Product
Terminated
- B Cell Lymphomas
- +3 more
- ACTR T Cell Product
-
Gilbert, Arizona
- +15 more
Oct 4, 2021
Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)
Completed
- Acute Leukemia
- +4 more
-
Atlanta, GeorgiaNorthside Hospital
Sep 1, 2021
Multiple Myeloma Trial in United States (hLL1-DOX (the doxorubicin conjugate of milatuzumab))
Terminated
- Multiple Myeloma
- hLL1-DOX (the doxorubicin conjugate of milatuzumab)
-
Orlando, Florida
- +4 more
Aug 12, 2021
Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA Trial in United States (milatuzumab)
Completed
- Multiple Myeloma
- +2 more
- milatuzumab
-
Atlanta, Georgia
- +5 more
Aug 12, 2021
Multiple Myeloma Trial in United States (MyHOPE™ for Multiple Myeloma, MyHope HCP Portal)
Terminated
- Multiple Myeloma
- MyHOPE™ for Multiple Myeloma
- MyHope HCP Portal
-
Mobile, Alabama
- +33 more
Aug 5, 2021
Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)
Completed
- Multiple Myeloma
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- +4 more
-
Birmingham, Alabama
- +30 more
Mar 31, 2021
Multiple Myeloma Trial in Worldwide (panobinostat capsules, bortezomib injection, dexamethasone tablets)
Active, not recruiting
- Multiple Myeloma
- panobinostat capsules
- +2 more
-
Fayetteville, Arkansas
- +79 more
Mar 15, 2021
Multiple Myeloma Trial in United States (bb21217)
Active, not recruiting
- Multiple Myeloma
- bb21217
-
San Francisco, California
- +10 more
Mar 17, 2021
Connect® MM- The Multiple Myeloma Disease Registry
Active, not recruiting
- Multiple Myeloma
-
Huntsville, Alabama
- +252 more
Jan 21, 2021
Multiple Myeloma Trial in United States (Denosumab Q4W)
Recruiting
- Multiple Myeloma
- Denosumab Q4W
-
Atlanta, Georgia
- +6 more
Jan 21, 2021